Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medicaid | 9 | 2014 | 257 | 1.680 |
Why?
|
| Quality of Health Care | 9 | 2008 | 187 | 1.600 |
Why?
|
| Arkansas | 27 | 2015 | 1985 | 1.110 |
Why?
|
| Quality Indicators, Health Care | 5 | 2008 | 86 | 0.910 |
Why?
|
| Medicare | 4 | 2006 | 249 | 0.830 |
Why?
|
| Delivery of Health Care | 5 | 2008 | 310 | 0.700 |
Why?
|
| Patient-Centered Care | 2 | 2012 | 131 | 0.620 |
Why?
|
| Practice Guidelines as Topic | 7 | 2008 | 449 | 0.580 |
Why?
|
| Reimbursement Mechanisms | 3 | 2014 | 23 | 0.540 |
Why?
|
| Drug Prescriptions | 2 | 2006 | 97 | 0.500 |
Why?
|
| Reimbursement, Incentive | 2 | 2013 | 13 | 0.480 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2014 | 50 | 0.450 |
Why?
|
| Health Policy | 1 | 2014 | 154 | 0.430 |
Why?
|
| Episode of Care | 1 | 2012 | 4 | 0.420 |
Why?
|
| Humans | 38 | 2015 | 50208 | 0.420 |
Why?
|
| Appointments and Schedules | 1 | 2012 | 23 | 0.410 |
Why?
|
| Cesarean Section | 1 | 2013 | 187 | 0.400 |
Why?
|
| United States | 11 | 2014 | 4874 | 0.400 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2004 | 160 | 0.400 |
Why?
|
| Hypertension | 2 | 2007 | 537 | 0.390 |
Why?
|
| Quality Assurance, Health Care | 1 | 2012 | 149 | 0.380 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 3 | 2006 | 74 | 0.380 |
Why?
|
| Adolescent Health Services | 1 | 2011 | 7 | 0.380 |
Why?
|
| Asthma | 3 | 2004 | 280 | 0.380 |
Why?
|
| Child Health Services | 1 | 2011 | 77 | 0.350 |
Why?
|
| Drug Utilization Review | 1 | 2009 | 23 | 0.340 |
Why?
|
| Efficiency, Organizational | 2 | 2015 | 41 | 0.330 |
Why?
|
| Pregnancy Complications | 1 | 2013 | 382 | 0.330 |
Why?
|
| Child Behavior Disorders | 1 | 2009 | 79 | 0.320 |
Why?
|
| Mental Health Services | 1 | 2011 | 199 | 0.310 |
Why?
|
| Primary Health Care | 1 | 2012 | 360 | 0.310 |
Why?
|
| Efficiency | 1 | 2008 | 32 | 0.310 |
Why?
|
| Chemoprevention | 2 | 2006 | 15 | 0.310 |
Why?
|
| Total Quality Management | 1 | 2008 | 23 | 0.310 |
Why?
|
| Health Services Accessibility | 1 | 2012 | 399 | 0.300 |
Why?
|
| Benchmarking | 1 | 2008 | 61 | 0.300 |
Why?
|
| Sociology, Medical | 1 | 2007 | 3 | 0.290 |
Why?
|
| Antipsychotic Agents | 1 | 2009 | 232 | 0.290 |
Why?
|
| Insurance, Pharmaceutical Services | 2 | 2006 | 26 | 0.280 |
Why?
|
| Evidence-Based Medicine | 1 | 2008 | 247 | 0.280 |
Why?
|
| Polypharmacy | 1 | 2006 | 14 | 0.270 |
Why?
|
| Risk Factors | 7 | 2013 | 3629 | 0.270 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2006 | 43 | 0.270 |
Why?
|
| Bipolar Disorder | 1 | 2008 | 192 | 0.270 |
Why?
|
| Pediatrics | 1 | 2009 | 279 | 0.270 |
Why?
|
| Community-Acquired Infections | 2 | 2003 | 39 | 0.270 |
Why?
|
| Pharyngitis | 1 | 2006 | 16 | 0.270 |
Why?
|
| Mass Screening | 3 | 2005 | 346 | 0.270 |
Why?
|
| Patient Compliance | 1 | 2007 | 230 | 0.260 |
Why?
|
| Thromboembolism | 1 | 2006 | 54 | 0.260 |
Why?
|
| Diabetes Complications | 1 | 2006 | 119 | 0.260 |
Why?
|
| Chlamydia Infections | 2 | 2005 | 77 | 0.250 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2007 | 172 | 0.250 |
Why?
|
| Venous Thrombosis | 1 | 2006 | 90 | 0.250 |
Why?
|
| Bacterial Infections | 1 | 2006 | 96 | 0.250 |
Why?
|
| Respiratory Tract Infections | 1 | 2006 | 76 | 0.250 |
Why?
|
| Anti-Infective Agents | 1 | 2006 | 95 | 0.250 |
Why?
|
| Benzodiazepines | 1 | 2005 | 73 | 0.250 |
Why?
|
| Nursing Homes | 2 | 2002 | 114 | 0.250 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2005 | 29 | 0.250 |
Why?
|
| Telemedicine | 1 | 2011 | 449 | 0.240 |
Why?
|
| Hemophilia B | 1 | 2004 | 4 | 0.240 |
Why?
|
| Physicians | 1 | 2008 | 230 | 0.240 |
Why?
|
| Vaginal Smears | 1 | 2004 | 27 | 0.240 |
Why?
|
| Diagnostic Errors | 1 | 2004 | 63 | 0.240 |
Why?
|
| Hemophilia A | 1 | 2004 | 25 | 0.230 |
Why?
|
| Blood Pressure | 1 | 2006 | 524 | 0.230 |
Why?
|
| Trust | 1 | 2004 | 59 | 0.230 |
Why?
|
| Renal Dialysis | 1 | 2005 | 170 | 0.230 |
Why?
|
| Anemia, Sickle Cell | 1 | 2004 | 96 | 0.220 |
Why?
|
| Anxiety | 1 | 2005 | 275 | 0.220 |
Why?
|
| Referral and Consultation | 1 | 2005 | 285 | 0.220 |
Why?
|
| Government Regulation | 1 | 2002 | 14 | 0.210 |
Why?
|
| Education, Medical, Continuing | 1 | 2003 | 68 | 0.210 |
Why?
|
| Attitude to Health | 1 | 2004 | 191 | 0.210 |
Why?
|
| Information Services | 1 | 2002 | 12 | 0.210 |
Why?
|
| Medical Audit | 1 | 2002 | 21 | 0.210 |
Why?
|
| Pneumonia | 1 | 2003 | 118 | 0.200 |
Why?
|
| Ambulatory Care | 1 | 2003 | 222 | 0.190 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2004 | 276 | 0.190 |
Why?
|
| Child | 6 | 2011 | 6851 | 0.180 |
Why?
|
| Prenatal Care | 1 | 2002 | 109 | 0.180 |
Why?
|
| Clinical Competence | 2 | 2008 | 392 | 0.180 |
Why?
|
| Program Development | 2 | 2012 | 167 | 0.170 |
Why?
|
| Patient Education as Topic | 3 | 2007 | 313 | 0.150 |
Why?
|
| Anti-Bacterial Agents | 1 | 2003 | 747 | 0.140 |
Why?
|
| Blood Specimen Collection | 1 | 2015 | 34 | 0.130 |
Why?
|
| Neonatal Screening | 1 | 2015 | 47 | 0.120 |
Why?
|
| Uncompensated Care | 1 | 2014 | 3 | 0.120 |
Why?
|
| Federal Government | 1 | 2014 | 4 | 0.120 |
Why?
|
| Guideline Adherence | 2 | 2008 | 133 | 0.120 |
Why?
|
| Economics, Hospital | 1 | 2014 | 11 | 0.120 |
Why?
|
| Financing, Government | 1 | 2014 | 23 | 0.120 |
Why?
|
| State Government | 1 | 2014 | 43 | 0.120 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2005 | 61 | 0.110 |
Why?
|
| Pregnancy | 3 | 2013 | 2604 | 0.110 |
Why?
|
| Adrenergic beta-Agonists | 2 | 2004 | 40 | 0.110 |
Why?
|
| Quality Improvement | 1 | 2015 | 209 | 0.110 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2004 | 94 | 0.100 |
Why?
|
| Poverty | 1 | 2014 | 199 | 0.100 |
Why?
|
| Adolescent | 3 | 2011 | 6390 | 0.100 |
Why?
|
| Risk Assessment | 2 | 2006 | 1262 | 0.100 |
Why?
|
| Female | 7 | 2013 | 26635 | 0.100 |
Why?
|
| Infant, Newborn | 4 | 2015 | 2766 | 0.100 |
Why?
|
| Consultants | 1 | 2011 | 5 | 0.100 |
Why?
|
| Neonatology | 1 | 2011 | 13 | 0.100 |
Why?
|
| Certification | 1 | 2011 | 49 | 0.090 |
Why?
|
| Prevalence | 1 | 2013 | 951 | 0.090 |
Why?
|
| Premature Birth | 1 | 2011 | 147 | 0.080 |
Why?
|
| Physician's Role | 1 | 2007 | 47 | 0.070 |
Why?
|
| Aged, 80 and over | 2 | 2006 | 3154 | 0.070 |
Why?
|
| Organizational Culture | 1 | 2007 | 43 | 0.070 |
Why?
|
| Drug Monitoring | 1 | 2007 | 78 | 0.070 |
Why?
|
| Infant | 2 | 2006 | 3563 | 0.070 |
Why?
|
| Child, Preschool | 2 | 2006 | 3883 | 0.070 |
Why?
|
| Psychiatry | 1 | 2008 | 105 | 0.070 |
Why?
|
| Drug Incompatibility | 1 | 2006 | 1 | 0.070 |
Why?
|
| Methylphenidate | 1 | 2007 | 75 | 0.070 |
Why?
|
| Secondary Prevention | 1 | 2006 | 78 | 0.070 |
Why?
|
| Physician-Patient Relations | 1 | 2007 | 141 | 0.070 |
Why?
|
| Drug Resistance | 1 | 2006 | 64 | 0.070 |
Why?
|
| Anti-Asthmatic Agents | 2 | 2002 | 30 | 0.060 |
Why?
|
| Brachial Artery | 1 | 2005 | 15 | 0.060 |
Why?
|
| Polytetrafluoroethylene | 1 | 2005 | 32 | 0.060 |
Why?
|
| Arm | 1 | 2005 | 47 | 0.060 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2005 | 19 | 0.060 |
Why?
|
| Radial Artery | 1 | 2005 | 31 | 0.060 |
Why?
|
| Hemoglobin SC Disease | 1 | 2004 | 5 | 0.060 |
Why?
|
| Hemoglobin, Sickle | 1 | 2004 | 6 | 0.060 |
Why?
|
| Sickle Cell Trait | 1 | 2004 | 3 | 0.060 |
Why?
|
| Community Networks | 1 | 2005 | 50 | 0.060 |
Why?
|
| Veins | 1 | 2005 | 71 | 0.060 |
Why?
|
| Blood Coagulation Factors | 1 | 2004 | 17 | 0.060 |
Why?
|
| Central Nervous System Stimulants | 1 | 2007 | 213 | 0.060 |
Why?
|
| Administration, Inhalation | 1 | 2004 | 108 | 0.060 |
Why?
|
| Drug Utilization | 1 | 2004 | 77 | 0.060 |
Why?
|
| Homeostasis | 1 | 2004 | 201 | 0.050 |
Why?
|
| Hospitals, Pediatric | 1 | 2004 | 236 | 0.050 |
Why?
|
| Inhalation Spacers | 1 | 2002 | 7 | 0.050 |
Why?
|
| Peak Expiratory Flow Rate | 1 | 2002 | 9 | 0.050 |
Why?
|
| Pneumonia, Bacterial | 1 | 2003 | 27 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 487 | 0.050 |
Why?
|
| Frail Elderly | 1 | 2002 | 32 | 0.050 |
Why?
|
| Immunization | 1 | 2002 | 67 | 0.050 |
Why?
|
| Infant, Low Birth Weight | 1 | 2002 | 62 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2004 | 571 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2002 | 381 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2004 | 951 | 0.050 |
Why?
|
| Aged | 2 | 2006 | 9405 | 0.050 |
Why?
|
| Hospitalization | 1 | 2004 | 655 | 0.040 |
Why?
|
| Pneumonia, Viral | 1 | 2003 | 169 | 0.040 |
Why?
|
| Prognosis | 1 | 2004 | 1954 | 0.040 |
Why?
|
| Heart Failure | 1 | 2005 | 506 | 0.040 |
Why?
|
| Smoking Cessation | 1 | 2002 | 300 | 0.040 |
Why?
|
| Male | 3 | 2004 | 25399 | 0.040 |
Why?
|
| Time Factors | 1 | 2005 | 2922 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2002 | 286 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2002 | 1422 | 0.040 |
Why?
|
| Myocardial Infarction | 1 | 2002 | 396 | 0.040 |
Why?
|
| Aging | 1 | 2002 | 688 | 0.040 |
Why?
|
| Hospitals | 1 | 2011 | 175 | 0.020 |
Why?
|
| Durable Medical Equipment | 1 | 2002 | 3 | 0.010 |
Why?
|
| Pharmacies | 1 | 2002 | 61 | 0.010 |
Why?
|